Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- NMRA
- Price
- 0.79
- Stock movement up
- +0.03 (1.86%)
- Company name
- Neumora Therapeutics, Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markedsverdi
- 265.59M
- Ent verdi
- -
- Pris/omsetning
- -
- Pris/bok
- -
- Utbytte avkastning
- -
- Utbytte vekst
- -
- Vekst år
- -
- FCF-utbetaling
- -
- Etterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års avkastning
- -86.16%
- 3 års avkastning
- -
- 5 års avkastning
- -
- 10 års avkastning
- -
Sist oppdatert: 2025-09-15
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UTBYTTE
NMRA betaler ikke utbytte
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VERDSETTELSE
Verdsettelsesforhold
Loading...
Verdsettelsesforhold-data
| Etterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Verdsettelse (Salg/Bokført verdi)
Loading...
Verdsettelse (Salg/Bokført verdi) data
| Pris til omsetning | - |
| Pris til bok | - |
| EV i forhold til salg | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
ØKONOMI
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
AKSJEINFORMASJON
Aksjediagram
Loading...
Aksjekurs-data
| Åpning | 1.59 |
| Daglig høy | 1.65 |
| Daglig lav | 1.57 |
| Daglig volum | 324K |
| Tidenes høyeste | 19.76 |
| 1 år analytikerestimat | 6.05 |
| Beta | - |
| EPS (TTM) | - |
| Utbytte per aksje | - |
| Ex-div dato | - |
| Neste dato for resultatpresentasjon | 29 Oct 2025 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| NMRA | S&P500 | |
| Nåværende prisfall fra toppnotering | -91.70% | -1.46% |
| Høyeste prisfall | -96.89% | -56.47% |
| Dato for høyeste fall | 14 May 2025 | 9 Mar 2009 |
| Gj.snittlig fall fra topp | -52.86% | -10.99% |
| Gj.snittlig tid til ny topp | 61 days | 12 days |
| Maks tid til ny topp | 379 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
SELSKAPSOPPLYSNINGER
Markedsverdi
265.59M
Markedsverdi kategori
Small-cap
Beskrivelse
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease. In addition, the company's preclinical phase product includes NMRA-NMDA and NMRA-M4R for the treatment of Schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
Ansatte
96
Nettsted
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Land
USA
By
Aksjetype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Seeking AlphaPressemeldinger
iO Charts is a Seeking Alpha partnerNeste side